March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Recessive Mutations in the PLA2G5 Gene, Encoding Group V Phospholipase A2, Cause Benign Fleck Retina
Author Affiliations & Notes
  • Panagiotis I. Sergouniotis
    Genetics, Inherited Eye Disease,
    UCL Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Alice E. Davidson
    Genetics, Inherited Eye Disease,
    UCL Institute of Ophthalmology, London, United Kingdom
  • Donna S. Mackay
    Genetics, Inherited Eye Disease,
    UCL Institute of Ophthalmology, London, United Kingdom
  • Anthony G. Robson
    Genetics, Inherited Eye Disease,
    Visual Neuroscience, Electrophysiology,
    UCL Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Timothy W. Isaacs
    Lions Eye Institute, Nedlands, Australia
  • Graham E. Holder
    Genetics, Inherited Eye Disease,
    Visual Neuroscience, Electrophysiology,
    UCL Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Glen Jeffery
    Visual Neuroscience, Electrophysiology,
    UCL Institute of Ophthalmology, London, United Kingdom
  • Vincent Plagnol
    UCL Genetics Institute, London, United Kingdom
  • Anthony T. Moore
    Genetics, Inherited Eye Disease,
    UCL Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Andrew R. Webster
    Genetics, Inherited Eye Disease,
    UCL Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships  Panagiotis I. Sergouniotis, None; Alice E. Davidson, None; Donna S. Mackay, None; Anthony G. Robson, None; Timothy W. Isaacs, None; Graham E. Holder, None; Glen Jeffery, None; Vincent Plagnol, None; Anthony T. Moore, None; Andrew R. Webster, None
  • Footnotes
    Support  RP Fighting Blindness, Fight for Sight, Moorfields Eye Hospital Special Trustees, National Institute for Health Research UK (UCLH, MEH & IOO Biomedical Research Councils),Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2253. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Panagiotis I. Sergouniotis, Alice E. Davidson, Donna S. Mackay, Anthony G. Robson, Timothy W. Isaacs, Graham E. Holder, Glen Jeffery, Vincent Plagnol, Anthony T. Moore, Andrew R. Webster; Recessive Mutations in the PLA2G5 Gene, Encoding Group V Phospholipase A2, Cause Benign Fleck Retina. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2253.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the molecular pathology of benign fleck retina, an autosomal recessive condition associated with yellow-white, fleck-like retinal lesions and no apparent visual or electrophysiological deficits.

Methods: : Single-nucleotide polymorphism arrays (Affymetrix) were utilised to perform homozygosity mapping in a consanguineous family with three affected siblings (family J). Subsequently, DNA from an affected family member was analysed using exon capture and high-throughput sequencing (Agilent SureSelect 38 Mb exome, Illumina HiSeq2000 sequencer). Sanger sequencing of PLA2G5 was performed on DNA from four additional unrelated individuals with benign fleck retina. Clinical investigations performed included spectral domain optical coherence tomography (SD-OCT), fundus autofluorescence imaging, electrophysiology and fundus-controlled perimetry. Immunohistochemistry on human retinal sections was undertaken to determine the precise localisation of group V phospholipase A2 (PLA2).

Results: : A homozygous, likely disease-associated missense variant in PLA2G5 (c.133G>T, p.Gly45Cys) was identified in affected individuals from family J. Biallelic missense and nonsense changes in the same gene were detected in three additional patients with the same diagnosis. In contrast, no loss of function or common (minor-allele frequency > 0.05%) non-synonymous PLA2G5 variants have been previously reported (exome variant server, dbSNP, 1000 genomes project) or were detected in an internal database of 224 exomes. No visual or electrophysiological deficits were detected in any patient. SD-OCT and fundus autofluorescence imaging revealed endogenously fluorescent lesions at the level of the retinal pigment epithelium. Despite defective group V PLA2 being associated with conditions such as asthma and atherosclerosis in Pla2g5-deficient mice, patients did not report any medical history of major illness; two had mildly elevated low-density lipoprotein levels. Unexpectedly, immunohistochemical staining of human retinal tissue revealed localization of the protein predominantly in the inner and outer plexiform layers.

Conclusions: : Defects in a secretory phospholipase, group V phospholipase A2, cause benign fleck retina. This finding facilitates differential diagnosis of this benign condition from other fleck retina syndromes associated with abnormal retinal function. The composition of the flecks and the precise role of group V PLA2 in the human retina remain to be determined.

Keywords: genetics • retina • gene mapping 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×